There is an immediate need for health professionals to start watching for the signs of Obstructive Sleep Apnea and get their patients tested. We all need to work together to develop a clear path.
Washington, D.C. (PRWEB) September 24, 2015
On September 21, Dr. Elliott J. Alpher of The Alpher Center invited senior leaders of distinguished organizations to tackle Obstructive Sleep Apnea (OSA) during a one-day gathering.
The significance of this exploratory collaboration between The Alpher Center, The National Heart Foundation, The NFL Players Association, KaVo Kerr Group, Kosmo Technologies, and FOCUS Investment Banking is in full alignment to bring greater awareness and involvement for identifying and diagnosing Sleep Apnea. “There is an immediate need for health professionals to start watching for the signs of Obstructive Sleep Apnea and get their patients tested. We all need to work together to develop a clear path,” says Dr. Alpher.
There is a void of awareness in diagnosing this condition. Obstructive Sleep Apnea affects about 25 million adults, and more than 80% are undiagnosed. Obstructive Sleep Apna (OSA) is a potentially life-threatening condition, including an increased risk of stroke, heart disease, impaired concentration, mood changes, impaired glucose tolerance and insulin resistance.
Dr. Elliott Alpher, one of the District’s most experienced specialists for sleep and jaw disorders, on staff at George Washington University Hospital and Georgetown University Hospital, has been known as a leader in the treatment of sleep disorders and jaw pain for 25 years. Dr. Alpher has pioneered a conservative, non-invasive approach utilizing computerized and verifiable diagnostic methods to treat TMD, snoring and sleep apnea. This method of treatment has proven to be greatly successful and is highly regarded as the first method of choice by Physicians and patients.
Dr. Alpher was also recently responsible for heading a delegation to the Federal Motor Carrier Safety Administration (FMCSA) and Medical Advisory Board (MAB) to introduce the new technology of compliance chips in oral appliances to treat and monitor sleep apnea and snoring of truckers and other transportation personnel. In addition, he earned the status of Diplomate of the American Board of Craniofacial Pain & Dental Sleep Medicine in October 2013 and serves as a Board member. Dr. Alpher is also a Board member and Diplomate to the Board of the American Sleep and Breathing Academy since March of 2014.
About Living Heart Foundation
The Living Heart Foundation (LHF) is a nonprofit organization under IRS 501 (c) (3) code. The LHF was initially funded by a grant from the Edison Foundation. Subsequently, Funding sources and donations have been obtained from companies like Covidien, Pfizer, Meridian Health System, Siemens, Professional Athletes Foundation, and from individual sources. The LHF was established by Arthur J. Roberts, MD in April 2001 to combat sudden cardiac death and to provide cardiovascular risk stratification with early preventive intervention for cardiac, pulmonary, and metabolic conditions through on-site screening and integrated follow-up health programs. The LHF has published 10 peer review papers related to CV risk in college students & athletes, as well as former NFL athletes.
About The NFL PLAYERS ASSOCIATION
The National Football League Players Association (NFLPA) is a non-profit, professional sports union that protects the best interests and welfare of all NFL players. Established in 1956, the NFLPA is governed by a Board of Player Representatives, acting in accordance with the NFLPA Constitution and federal labor laws. The NFLPA’s responsibilities include: Representing all players in matters concerning wages, hours and working conditions and protecting their rights as professional football players; ensuring that the terms of the Collective Bargaining Agreement are met; negotiating and monitoring retirement and insurance benefits; providing other member services and activities; providing assistance to charitable and community organizations; enhancing and defending the image of players and their profession, on and off the field.
About KaVo Kerr Group
KaVo Kerr Group is a global portfolio of leading dental brands that share common values of Trust, Experience, Choices, Quality and Smart Innovation. Brands include KaVo, Kerr, i-CAT, Gendex, NOMAD, Instrumentarium, SOREDEX, DEXIS, Pelton & Crane, Marus, Pentron, Orascoptic, Ormco and Implant Direct. With over 500 years of combined experience and proven solutions, KaVo Kerr Group uniquely serves 99% if all dental practices.
About Kosmo Technologies
Kosmo Technologies is a research and product development company for doctors in the field of Dental Sleep, Functional Orthodontics, Orthodontics, TMD, neuromuscular Dentistry and Sleep Medicine. Debut product is the Andra Gauge, designed to allow the practitioner to have control over the patient’s mandible in relationship to the maxilla in all three axes (anterior-posterior, vertical and sagittal).
About Focus Investment Banking
FOCUS Investment Banking LLC provides middle market investment banking services to entrepreneurs, corporate owners, and investors across a broad range of industries both domestically and worldwide. With offices in major cities across the US, FOCUS specializes in providing mergers, acquisitions, divestitures, and corporate finance services to business units with transactions or revenues in the $5-300 million range.